Guoyi Yan

机构：Xinxiang University · ORCID：0000-0002-3953-6190

发表论文 53 篇 · 总被引 811 次 · h-index 16

代表论文

• Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer (2022 · European Journal of Medicinal Chemistry · 被引 45)
• LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma (2022 · Laboratory Investigation · 被引 42)
• Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities (2021 · European Journal of Medicinal Chemistry · 被引 39)
• Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold (2021 · European Journal of Medicinal Chemistry · 被引 23)
• Recent advances in dual PROTACs degrader strategies for disease treatment (2024 · European Journal of Medicinal Chemistry · 被引 21)
• Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design (2021 · Journal of Medicinal Chemistry · 被引 11)